0
Business
Teva acquires Emalex Biosciences for up to $900m
April 29, 2026
Scroll
Posted 1 hour ago by
The Israeli pharmaceutical company has also announced first quarter results, which beat the analysts’ predictions.
Globes English
Coverage and analysis from Israel. All insights are generated by our AI narrative analysis engine.
Israel
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.